These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1237 related articles for article (PubMed ID: 22108192)

  • 21. lncRNA CCAT1 is a biomarker for the proliferation and drug resistance of esophageal cancer via the miR-143/PLK1/BUBR1 axis.
    Hu M; Zhang Q; Tian XH; Wang JL; Niu YX; Li G
    Mol Carcinog; 2019 Dec; 58(12):2207-2217. PubMed ID: 31544294
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Calreticulin promotes cell motility and enhances resistance to anoikis through STAT3-CTTN-Akt pathway in esophageal squamous cell carcinoma.
    Du XL; Yang H; Liu SG; Luo ML; Hao JJ; Zhang Y; Lin DC; Xu X; Cai Y; Zhan QM; Wang MR
    Oncogene; 2009 Oct; 28(42):3714-22. PubMed ID: 19684620
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Polo-like kinase 1 inhibition kills glioblastoma multiforme brain tumor cells in part through loss of SOX2 and delays tumor progression in mice.
    Lee C; Fotovati A; Triscott J; Chen J; Venugopal C; Singhal A; Dunham C; Kerr JM; Verreault M; Yip S; Wakimoto H; Jones C; Jayanthan A; Narendran A; Singh SK; Dunn SE
    Stem Cells; 2012 Jun; 30(6):1064-75. PubMed ID: 22415968
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of PLK1 inhibition on cisplatin-resistant gastric cancer cells.
    Chen Z; Chai Y; Zhao T; Li P; Zhao L; He F; Lang Y; Qin J; Ju H
    J Cell Physiol; 2019 May; 234(5):5904-5914. PubMed ID: 30488440
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Overexpression of STAT3 potentiates growth, survival, and radioresistance of non-small-cell lung cancer (NSCLC) cells.
    Yin ZJ; Jin FG; Liu TG; Fu EQ; Xie YH; Sun RL
    J Surg Res; 2011 Dec; 171(2):675-83. PubMed ID: 20605584
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Persistent activation of stat3 signaling induces survivin gene expression and confers resistance to apoptosis in human breast cancer cells.
    Gritsko T; Williams A; Turkson J; Kaneko S; Bowman T; Huang M; Nam S; Eweis I; Diaz N; Sullivan D; Yoder S; Enkemann S; Eschrich S; Lee JH; Beam CA; Cheng J; Minton S; Muro-Cacho CA; Jove R
    Clin Cancer Res; 2006 Jan; 12(1):11-9. PubMed ID: 16397018
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Overexpression of Plk1 promotes malignant progress in human esophageal squamous cell carcinoma.
    Zhao C; Gong L; Li W; Chen L
    J Cancer Res Clin Oncol; 2010 Jan; 136(1):9-16. PubMed ID: 19572149
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A small interfering RNA targeting NF-κB p65 alone or combined with 5-FU inhibits growth of esophageal squamous cell carcinoma in nude mice.
    Tian F; Fan T; Jiang Y; Zhang X; Wang X
    Pathol Res Pract; 2012 Jan; 208(1):32-8. PubMed ID: 22186294
    [TBL] [Abstract][Full Text] [Related]  

  • 29. BI 2536, a potent and selective inhibitor of polo-like kinase 1, inhibits tumor growth in vivo.
    Steegmaier M; Hoffmann M; Baum A; Lénárt P; Petronczki M; Krssák M; Gürtler U; Garin-Chesa P; Lieb S; Quant J; Grauert M; Adolf GR; Kraut N; Peters JM; Rettig WJ
    Curr Biol; 2007 Feb; 17(4):316-22. PubMed ID: 17291758
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tumorigenic role of podoplanin in esophageal squamous-cell carcinoma.
    Rahadiani N; Ikeda J; Makino T; Tian T; Qiu Y; Mamat S; Wang Y; Doki Y; Aozasa K; Morii E
    Ann Surg Oncol; 2010 May; 17(5):1311-23. PubMed ID: 20066519
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stomatin-like protein 2 is overexpressed in cancer and involved in regulating cell growth and cell adhesion in human esophageal squamous cell carcinoma.
    Zhang L; Ding F; Cao W; Liu Z; Liu W; Yu Z; Wu Y; Li W; Li Y; Liu Z
    Clin Cancer Res; 2006 Mar; 12(5):1639-46. PubMed ID: 16533792
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of PTK6, via RNA sequencing analysis, as a suppressor of esophageal squamous cell carcinoma.
    Ma S; Bao JYJ; Kwan PS; Chan YP; Tong CM; Fu L; Zhang N; Tong AHY; Qin YR; Tsao SW; Chan KW; Lok S; Guan XY
    Gastroenterology; 2012 Sep; 143(3):675-686.e12. PubMed ID: 22705009
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Polo-like kinase 1 is a therapeutic target in high-risk neuroblastoma.
    Ackermann S; Goeser F; Schulte JH; Schramm A; Ehemann V; Hero B; Eggert A; Berthold F; Fischer M
    Clin Cancer Res; 2011 Feb; 17(4):731-41. PubMed ID: 21169242
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Downregulation of miR-138 sustains NF-κB activation and promotes lipid raft formation in esophageal squamous cell carcinoma.
    Gong H; Song L; Lin C; Liu A; Lin X; Wu J; Li M; Li J
    Clin Cancer Res; 2013 Mar; 19(5):1083-93. PubMed ID: 23319823
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Overexpression of polo-like kinase 1 and its clinical significance in human non-small cell lung cancer.
    Wang ZX; Xue D; Liu ZL; Lu BB; Bian HB; Pan X; Yin YM
    Int J Biochem Cell Biol; 2012 Jan; 44(1):200-10. PubMed ID: 22064247
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Inhibition of PDK1 gene expression in esophageal cancer EC9706 cells by RNA interference and its effect on their malignant biological behavior].
    Yu J; Chen KS; Li YN; Yang J; Zhao L
    Zhonghua Zhong Liu Za Zhi; 2011 Jun; 33(6):410-4. PubMed ID: 21875479
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Activation of JAK2/STAT3 signaling by osteopontin promotes tumor growth in human breast cancer cells.
    Behera R; Kumar V; Lohite K; Karnik S; Kundu GC
    Carcinogenesis; 2010 Feb; 31(2):192-200. PubMed ID: 19926637
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Polo-like Kinase-1 Regulates Myc Stabilization and Activates a Feedforward Circuit Promoting Tumor Cell Survival.
    Xiao D; Yue M; Su H; Ren P; Jiang J; Li F; Hu Y; Du H; Liu H; Qing G
    Mol Cell; 2016 Nov; 64(3):493-506. PubMed ID: 27773673
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The vanillin derivative 6-bromine-5-hydroxy-4-methoxybenzaldehyde induces aberrant mitotic progression and enhances radio-sensitivity accompanying suppression the expression of PLK1 in esophageal squamous cell carcinoma.
    Gu MM; Li M; Gao D; Liu LH; Lang Y; Yang SM; Ou H; Huang B; Zhou PK; Shang ZF
    Toxicol Appl Pharmacol; 2018 Jun; 348():76-84. PubMed ID: 29679654
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Effect of antisense RNA targeting Polo-like kinase 1 on cell cycle of lung cancer cell line A549].
    Zhou Q; Bai M; Su Y
    Ai Zheng; 2005 Feb; 24(2):149-54. PubMed ID: 15694023
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 62.